Akebia Therapeutics Inc. (AKBA) slipped -6.85% or -0.4 to $5.5. It is about 1.01 million shares traded, which is 80.07% compare to the average total volume 1.26 million. The market cap of AKBA is $562.17 million. The year to date change is -67.37%. The 52 week price range is from $5.2 to $15.86. Price of AKBA have changed -8.37% during last week. It have changed -20.56% over last month, -32.46% over last 3 months, -43.06% over last 6 months and -60.99% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 7.89. It is 43.45% above current price. The 200-day Moving Averages for AKBA is 9.23. It is 67.82% above current price. The 52-week High is 15.86. It is 188.36% from the current price. The 52-week Low is 5.2. It is -5.45% from current price.
There are some statistics of AKBA. It is has market cap $562.17 million. The share outstanding is 102.12 million. The average volume is 1.26 million. The percent of top 15 Institution holding is 96.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -59.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -19.29%.